vorherige Seite4 of 53nächste Seite

Financial Statements

Bayer Group Consolidated Statements of Recognized Income and Expense

Note

2007

2008

€ million

€ million

Changes in fair values of derivatives designated as hedges,
recognized in stockholders’ equity


180

(110)

Changes in fair values of derivatives designated as hedges,
recognized in the income statement

[30.3]

(65)

(47)

Changes in fair values of available-for-sale financial assets,
recognized in stockholders’ equity


31

(32)

Changes in fair values of available-for-sale financial assets,
recognized in the income statement



(8)

1

Changes in actuarial gains  (losses) on defined benefit obligations for
pensions and other post-employment benefits and effects of the limitation
on pension plan assets, recognized in stockholders’ equity




1,355

(1,067)

Exchange differences on translation of operations outside the euro zone,
recognized in stockholders’ equity


(825)

(413)

Deferred taxes on valuation adjustments offset directly
against stockholders’ equity

[14]

(677)

505

Deferred taxes on valuation adjustments, removed from stockholders’ equity
and recognized in the income statement


20

14

Changes due to changes in the scope of consolidation

42

1

Revaluation surplus (IFRS 3)


-

8

Non-controlling interest in partnerships, recognized in liabilities


(36)

(15)

Valuation adjustments recognized directly in stockholders’ equity 

17

(1,155)

of which attributable to non-controlling interest

(3)

3

Income after taxes 

4,716

1,724

Total income and expense recognized in the financial statements 


4,733

569

of which attributable to non-controlling interest

2

8

of which attributable to Bayer AG stockholders

4,731

561

top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Search
Search
Download Center
 
 
Links
Services
 
 
 
 
Calendar
 
Info